Enantiomeric Agonists of the Type 2 Cannabinoid Receptor Reduce Retinal Damage during Proliferative Vitreoretinopathy and Inhibit Hyperactive Microglia In Vitro
Article in ACS Pharmacology & Translational Science (April 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Article in ACS Pharmacology & Translational Science (April 2024)
Article in Pharmaceutics (March 2023)
Article in Biosensors (September 2022)